Angiotensin II Type 1 Receptor Antibody-mediated Rejection Following Orthotopic Heart Transplant: A Single-center Experience.

Moreno, Jonathan D; Verma, Amanda K; Kopecky, Benjamin J; Dehner, Carina; Kostelecky, Nicolas; Vader, Justin M; Lin, Chieh-Yu; Schilling, Joel D

Moreno, Jonathan D; Verma, Amanda K; Kopecky, Benjamin J; Dehner, Carina; Kostelecky, Nicolas; Vader, Justin M; Lin, Chieh-Yu; Schilling, Joel D.

Afiliación

Moreno JD; Division of Cardiology, Department of Medicine, Washington University in St. Louis, St. Louis, MO.
Verma AK; Division of Cardiology, Department of Medicine, Washington University in St. Louis, St. Louis, MO.
Kopecky BJ; Division of Cardiology, Department of Medicine, Washington University in St. Louis, St. Louis, MO.
Dehner C; Department of Pathology & Immunology, Washington University in St. Louis, St. Louis, MO.
Kostelecky N; Department of Pathology & Immunology, Washington University in St. Louis, St. Louis, MO.
Vader JM; Division of Cardiology, Department of Medicine, Washington University in St. Louis, St. Louis, MO.
Lin CY; Department of Pathology & Immunology, Washington University in St. Louis, St. Louis, MO.
Schilling JD; Division of Cardiology, Department of Medicine, Washington University in St. Louis, St. Louis, MO.

Transplantation ; 106(2): 373-380, 2022 02 01.

Article en En | MEDLINE | ID: mdl-33988339

Asunto(s)

Trasplante de Corazón; Trasplante de Riñón; Antagonistas de Receptores de Angiotensina; Inhibidores de la Enzima Convertidora de Angiotensina; Rechazo de Injerto; Trasplante de Corazón/efectos adversos; Humanos; Receptor de Angiotensina Tipo 1; Estudios Retrospectivos; Volumen Sistólico; Función Ventricular Izquierda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Corazón / Trasplante de Riñón Tipo de estudio: Observational_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google